Harnessing the Versatility of Invariant NKT Cells in a Stepwise Approach to Sepsis Immunotherapy.
J Immunol
; 206(2): 386-397, 2021 01 15.
Article
in En
| MEDLINE
| ID: mdl-33310870
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Th2 Cells
/
Sepsis
/
Natural Killer T-Cells
/
Immunotherapy
Type of study:
Clinical_trials
Limits:
Animals
/
Humans
Language:
En
Journal:
J Immunol
Year:
2021
Type:
Article
Affiliation country:
Canada